AMENDED AND RESTATED CHANGE IN CONTROL AGREEMENTChange in Control Agreement • February 27th, 2009 • Allergan Inc • Pharmaceutical preparations • California
This Agreement (“Agreement”) dated as of , , is entered into by and between «Emply_NameFirst» «Employee_Last_Name» (“Employee”), and Allergan, Inc., a Delaware corporation (the “Company”).
FIRST AMENDMENT TO AMENDED AND RESTATED LICENSE, COMMERCIALIZATION AND SUPPLY AGREEMENTLicense Agreement • February 27th, 2009 • Allergan Inc • Pharmaceutical preparations • New York
THIS FIRST AMENDMENT TO AMENDED AND RESTATED LICENSE, COMMERCIALIZATION AND SUPPLY AGREEMENT (this “Amendment”), dated as of January 9, 2009 (the “Amendment Effective Date”), is entered into by and among Indevus Pharmaceuticals, Inc., a corporation organized and existing under the laws of the State of Delaware and having its principal office at 33 Hayden Avenue, Lexington, MA 02421 (“Indevus”), and Allergan USA, Inc., a corporation organized and existing under the laws of the State of Delaware and having its principal office at 2525 Dupont Drive, Irvine, CA 92612 (f/k/a Esprit Pharma, Inc.) (“Allergan”). Indevus and Allergan are collectively referred to herein as the “Parties”.
LICENSE, DEVELOPMENT, SUPPLY AND DISTRIBUTION AGREEMENT by and among ALLERGAN SALES, LLC, ALLERGAN USA, INC., ALLERGAN, INC. and SPECTRUM PHARMACEUTICALS, INC. dated October 28, 2008License, Development, Supply and Distribution Agreement • February 27th, 2009 • Allergan Inc • Pharmaceutical preparations • New York
**** Certain confidential information contained in this document, marked with four asterisks, has been omitted and filed separately with the Securities and Exchange Commission pursuant to Rule 24b-2 of the Securities Exchange Act of 1934, as amended.
This certificate also evidences and entitles the holder hereof to certain rights as set forth in an Agreement between Allergan, Inc. (the “Company”) and Wells Fargo Bank, NA., as successor Rights Agent, dated as of January 25, 2000, as the same may be...Rights Agreement • February 27th, 2009 • Allergan Inc • Pharmaceutical preparations
